tradingkey.logo
tradingkey.logo
Search

Vertex announces broad reimbursement agreement With NHS England for Alyftrek for the treatment of cystic fibrosis

ReutersJul 14, 2025 11:03 PM
facebooktwitterlinkedin
View all comments0

- Vertex Pharmaceuticals Inc VRTX.O:

  • VERTEX ANNOUNCES BROAD REIMBURSEMENT AGREEMENT WITH NHS ENGLAND FOR ALYFTREK® (DEUTIVACAFTOR/TEZACAFTOR/VANZACAFTOR) AN INNOVATIVE ONCE-DAILY CFTR MODULATOR FOR THE TREATMENT OF CYSTIC FIBROSIS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI